|
[1]
|
王道才, 谭美春, 施巍, 等. 血清PSGL-1、HPT、sCD14-ST对重症肺炎患者病情进展和预后评估价值[J]. 临床肺科杂志, 2025, 30(8): 1170-1175.
|
|
[2]
|
刘晓, 王彤, 蒋怡芳, 等. 重症社区与医院获得性肺炎临床特征与预后分析[J]. 中国感染与化疗杂志, 2018, 18(2): 163-170.
|
|
[3]
|
Nair, G.B. and Niederman, M.S. (2021) Updates on Community Acquired Pneumonia Management in the ICU. Pharmacology & Therapeutics, 217, Article ID: 107663. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
常越, 王金平. 亚胺培南西司他丁联合呼吸喹诺酮类药物治疗重症加强护理病房重症肺炎的临床疗效与安全性[J]. 中国药物经济学, 2024, 19(10): 81-83, 87.
|
|
[5]
|
于蕾, 姜薇薇, 李吉明. 老年急性缺血性脑卒中合并重症肺炎患者病原菌分布与T细胞亚群改变及预后[J]. 中华老年多器官疾病杂志, 2024, 23(9): 655-658.
|
|
[6]
|
中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版) [J]. 中华结核和呼吸杂志, 2016, 39(4): 253-279.
|
|
[7]
|
Ma, J., Li, L., Qie, X., Zhao, Q., Zhang, L., Xu, N., et al. (2023) Value of Combined Detection of PCT, CRP, and FIB in Differentiating Viral Infection from Bacterial Infection in Severe Pneumonia. Clinical Laboratory, 69, e230325. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
周敏, 王海波, 张强, 等. 重症肺炎伴ARDS患者的菌群分布及预后因素分析[J]. 中国城乡企业卫生, 2024, 39(9): 89-92.
|
|
[9]
|
李真, 张巧梅, 石瑞平, 等. 重症肺炎患者血清IL-17和TIM-4及TLR7水平变化及与预后的关系[J]. 感染、炎症、修复, 2025, 26(5): 334-338.
|
|
[10]
|
张婷婷, 王静, 杨丽. 老年重症肺炎病原菌分布及预后影响因素分析[J]. 中国卫生标准管理, 2025, 16(14): 91-95.
|
|
[11]
|
邓鑫. 重症监护室呼吸机相关性肺炎的影响因素及标准化护理对策研究[J]. 中国标准化, 2022(14): 246-249.
|
|
[12]
|
李帅, 张亚, 王静. 综合护理干预对降低ICU重症患者呼吸机相关性肺炎发生率的影响[J]. 中国医药指南, 2022, 20(17): 21-24.
|
|
[13]
|
朱景敏, 卢亚飞, 许敏霞, 等. 血液透析患者导管感染危险因素分析[J]. 中国现代医生, 2020, 58(22): 103-105, 109.
|
|
[14]
|
Al-Hasan, M.N. and Rac, H. (2020) Transition from Intravenous to Oral Antimicrobial Therapy in Patients with Uncomplicated and Complicated Bloodstream Infections. Clinical Microbiology and Infection, 26, 299-306. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Alali, M., Mayampurath, A., Dai, Y. and Bartlett, A.H. (2022) A Prediction Model for Bacteremia and Transfer to Intensive Care in Pediatric and Adolescent Cancer Patients with Febrile Neutropenia. Scientific Reports, 12, Article No. 7429. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
沈林华. 铜绿假单胞菌感染性肺炎患者的病原菌特征和肺表面活性蛋白B基因多态性和疾病进展与抗菌疗效的关系[J]. 中国现代医生, 2022, 60(29): 52-56, 61.
|
|
[17]
|
田苍松. 感染铜绿假单胞菌肺炎患者的治疗和预后研究[J]. 中国医药指南, 2018, 16(24): 47-48.
|
|
[18]
|
齐亚平. 铜绿假单胞菌肺炎治疗和预后的临床研究[J]. 首都食品与医药, 2017, 24(2): 28-29.
|
|
[19]
|
王睦天, 赵启亮, 张慧琪, 等. 铜绿假单胞菌肺炎转重症的风险因素及中药干预效果回顾性分析[J]. 中国中医急症, 2023, 32(12): 2078-2081.
|
|
[20]
|
Daikos, G.L., da Cunha, C.A., Rossolini, G.M., Stone, G.G., Baillon-Plot, N., Tawadrous, M., et al. (2021) Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas Aeruginosa. Antibiotics, 10, Article 1126. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
陈丽红, 肖曲香. 联合检测WBC、NLR、PLR、NEU%对急性加重期慢阻肺的预测价值[J]. 安徽医专学报, 2025, 24(4): 75-77.
|
|
[22]
|
陈秀琴, 黄玉麟, 汤俊. 重症肺炎患者血小板参数、OI值与患者治疗结局关系的多因素分析[J]. 临床和实验医学杂志, 2021, 20(11): 1195-1198.
|
|
[23]
|
Middleton, E.A., Weyrich, A.S. and Zimmerman, G.A. (2016) Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases. Physiological Reviews, 96, 1211-1259. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Weyrich, A.S. and Zimmerman, G.A. (2013) Platelets in Lung Biology. Annual Review of Physiology, 75, 569-591. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Li, X., Iwai, T., Nakamura, H., Inoue, Y., Chen, Y., Umeda, M., et al. (2008) An Ultrastructural Study of Porphyromonas Gingivalis-Induced Platelet Aggregation. Thrombosis Research, 122, 810-819. [Google Scholar] [CrossRef] [PubMed]
|